Related Experiment Video
Updated: Jul 5, 2026
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
Critique of coronary artery bypass surgery
Insights
For patients with single-vessel coronary artery disease and normal heart function, medical therapy is recommended. Surgery is generally advised only for symptom relief in specific cases, not for improved survival.
Area of Science:
- Cardiology
- Cardiac Surgery
- Internal Medicine
Background:
- Coronary artery disease (CAD) management varies based on disease extent and ventricular function.
- Optimal treatment strategies for different CAD severities remain a subject of ongoing clinical debate.
- Ventricular function, assessed by ejection fraction (EF), significantly influences treatment decisions and prognosis.
Purpose of the Study:
- To delineate optimal treatment strategies for coronary artery disease based on vessel involvement and left ventricular function.
- To evaluate the role of medical therapy versus surgical intervention for different presentations of coronary artery disease.
- To provide evidence-based recommendations for surgical intervention in patients with varying degrees of coronary artery disease and ventricular dysfunction.
Main Methods:
- Review and synthesis of current clinical evidence and expert opinion on surgical versus medical management of CAD.
- Stratification of patient populations based on number of diseased vessels (single-vessel, multivessel, left main) and ejection fraction (normal/mildly abnormal, moderate, poor).
- Analysis of survival data and symptomatic improvement associated with different treatment modalities in each patient subgroup.
Main Results:
- Patients with single-vessel CAD and preserved ejection fraction (>40%) have good prognosis with medical therapy; surgery is reserved for persistent symptoms.
- Surgical survival benefit is unclear for multivessel CAD with preserved ejection fraction; surgery recommended for symptom relief after medical failure.
- Left main CAD generally warrants surgical intervention due to evidence of improved survival; surgery is typically not advised for poor ventricular function (EF <30%) due to high risk and limited benefit.
Conclusions:
- Medical therapy is the cornerstone for single-vessel CAD with preserved ejection fraction.
- Surgical intervention for multivessel CAD should prioritize symptom management over survival benefits in patients with preserved ejection fraction.
- Treatment decisions for CAD must be individualized, considering vessel disease extent, ventricular function, and symptom profile, with surgery reserved for specific indications and after medical therapy failure in most cases.
Abstract:
Patients with single-vessel disease, with normal or mildly abnormal ventricular function (EF greater than 40%), have a good prognosis both for natural survival and long-range symptomatic improvement; therefore medical therapy is strongly recommended. Surgery is considered only if symptoms persist after aggressive medical therapy. It is possible that single-vessel left anterior descending disease is a special variant of this group, and surgery may, with further reports, show an increased survival. However, no adequately designed study has yet suggested this, and it is currently our opinion that patients with single-vessel disease do not have an improved survival following surgery. It is not clear whether surgery improves survival in patients with multivessel disease and normal or mildly abnormal ventricular function (EF greater than 40%). Consequently, cardiologists are divided as to whether to advise surgery in these patients solely for survival. Currently, it is our opinion that these patients should have surgery only for improvement of symptoms after failure of medical therapy. In left main coronary disease the evidence favoring improved survival after surgery has convinced most cardiologists, including ourselves, to recommend surgery. Patients with poor ventricular function (EF less than 30%) secondary to coronary artery disease often have congestive heart failure and not angina as their chief symptom. Surgery is usually not advisable for these patients, because of the increased operative mortality and lack of improvement in ventricular function. Patients with poor ventricular function with angina are not usually significantly improved by surgery. In patients with moderately abnormal ventricular function (EF = 30-40%), relief of angina is frequently obtained, but with some added surgical risk. We recommend surgery in these patients after aggressive medical therapy has failed. Patients with unstable angina are initially medically stabilized, after which they are generally managed as stable angina. Patients with persistence of pain at rest in spite of vigorous medical therapy are usually managed by early catheterization and surgery.
More Related Videos
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
01:26Coronary Artery Disease II: Pathophysiology
01:27Coronary Artery Disease V: Interprofessional Care
01:23Peripheral Artery Disease V: Postoperative Nursing Management